Primary B cell repertoire remodeling to achieve humoral transplantation tolerance

Seminars in Immunology

Volumn 24, Issue 2, 2012, Pages 109-114

  Parsons, Ronald F ^a   Redfield, Robert R ^a   Rodriguez, Eduardo ^a   Mustafa, Moiz M ^a   Vivek, Kumar ^a   Murayama, Michael ^a   Naji, Ali ^a   Noorchashm, Hooman ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

B lymphocytes; BLyS; Humoral tolerance; Transplantation

Indexed keywords

AUTOANTIGEN;

ANTIBODY RESPONSE; ANTIGEN PRESENTING CELL; B LYMPHOCYTE; GRAFT SURVIVAL; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOTHERAPY; NONHUMAN; REVIEW; T LYMPHOCYTE; TRANSPLANTATION TOLERANCE;

ANIMALS; B-CELL ACTIVATING FACTOR; B-LYMPHOCYTE SUBSETS; HUMANS; IMMUNOTHERAPY; ISOANTIBODIES; ISOANTIGENS; LYMPHOCYTE DEPLETION; TRANSPLANTATION TOLERANCE;

EID: 84859266285     PISSN: 10445323     EISSN: 10963618     Source Type: Journal    
DOI: 10.1016/j.smim.2011.08.016     Document Type: Review

References (54)

1. Wolfe R.A., Ashby V.B., Milford E.L., Ojo A.O., Ettenger R.E., Agodoa L.Y., et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999, 341:1725-1730.
2. Colvin R.B., Hirohashi T., Farris A.B., Minnei F., Collins A.B., Smith R.N. Emerging role of B cells in chronic allograft dysfunction. Kidney Int Suppl 2010, S13-S17.
3. Terasaki P.I., Ozawa M., Castro R. Four-year follow-up of a prospective trial of HLA and MICA antibodies on kidney graft survival. Am J Transplant 2007, 7:408-415.
4. Opelz G. Non-HLA transplantation immunity revealed by lymphocytotoxic antibodies. Lancet 2005, 365:1570-1576.
5. Parsons R.F., Vivek K., Redfield R.R., Migone T.S., Cancro M., Naji A., et al. B-cell tolerance in transplantation: is repertoire remodeling the answer?. Expert Rev Clin Immunol 2009, 5.
6. Kelishadi S.S., Azimzadeh A.M., Zhang T., Stoddard T., Welty E., Avon C., et al. Preemptive CD20+ B cell depletion attenuates cardiac allograft vasculopathy in cyclosporine-treated monkeys. J Clin Invest 2010, 120:1275-1284.
7. Nemazee D.A., Burki K. Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes. Nature 1989, 337:562-566.
8. Hartley S.B., Crosbie J., Brink R., Kantor A.B., Basten A., Goodnow C.C. Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens. Nature 1991, 353:765-769.
9. Halverson R., Torres R.M., Pelanda R. Receptor editing is the main mechanism of B cell tolerance toward membrane antigens. Nat Immunol 2004, 5:645-650.
10. Gay D., Saunders T., Camper S., Weigert M. Receptor editing: an approach by autoreactive B cells to escape tolerance. J Exp Med 1993, 177:999-1008.
11. Tiegs S.L., Russell D.M., Nemazee D. Receptor editing in self-reactive bone marrow B cells. J Exp Med 1993, 177:1009-1020.
12. Sprent J., Basten A. Circulating T and B lymphocytes of the mouse II. Lifespan. Cell Immunol 1973, 7:40-59.
13. Brahim F., Osmond D.G. Migration of bone marrow lymphocytes demonstrated by selective bone marrow labeling with thymidine-H3. Anat Rec 1970, 168:139-159.
14. Cyster J.G., Goodnow C.C. Antigen-induced exclusion from follicles and anergy are separate and complementary processes that influence peripheral B cell fate. Immunity 1995, 3:691-701.
15. Erikson J., Radic M.Z., Camper S.A., Hardy R.R., Carmack C., Weigert M. Expression of anti-DNA immunoglobulin transgenes in non-autoimmune mice. Nature 1991, 349:331-334.
16. Noorchashm H., Bui A., Li H.L., Eaton A., Mandik-Nayak L., Sokol C., et al. Characterization of anergic anti-DNA B cells: B cell anergy is a T cell-independent and potentially reversible process. Int Immunol 1999, 11:765-776.
17. Crowley J.E., Scholz J.L., Quinn W.J., Stadanlick J.E., Treml J.F., Treml L.S., et al. Homeostatic control of B lymphocyte subsets. Immunol Res 2008, 42:75-83.
18. Treml J.F., Hao Y., Stadanlick J.E., Cancro M.P. The BLyS family: toward a molecular understanding of B cell homeostasis. Cell Biochem Biophys 2009, 53:1-16.
19. Schiemann B., Gommerman J.L., Vora K., Cachero T.G., Shulga-Morskaya S., Dobles M., et al. An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Science 2001, 293:2111-2114.
20. Stadanlick J.E., Kaileh M., Karnell F.G., Scholz J.L., Miller J.P., Quinn W.J., et al. Tonic B cell antigen receptor signals supply an NF-kappaB substrate for prosurvival BLyS signaling. Nat Immunol 2008, 9:1379-1387.
21. Goodnow C.C., Sprent J., Fazekas de St Groth B., Vinuesa C.G. Cellular and genetic mechanisms of self tolerance and autoimmunity. Nature 2005, 435:590-597.
22. Mandik-Nayak L., Bui A., Noorchashm H., Eaton A., Erikson J., et al. Regulation of anti-double-stranded DNA B cells in nonautoimmune mice: localization to the T-B interface of the splenic follicle. J Exp Med 1997, 186:1257-1267.
23. Fulcher D.A., Basten A. Reduced life span of anergic self-reactive B cells in a double-transgenic model. J Exp Med 1994, 179:125-134.
24. Cyster J.G., Hartley S.B., Goodnow C.C. Competition for follicular niches excludes self-reactive cells from the recirculating B-cell repertoire. Nature 1994, 371:389-395.
25. Russell D.M., Dembic Z., Morahan G., Miller J.F., Burki K., Nemazee D. Peripheral deletion of self-reactive B cells. Nature 1991, 354:308-311.
26. Hondowicz B.D., Alexander S.T., Quinn W.J., Pagan A.J., Metzgar M.H., Erikson J. The role of BLyS/BLyS receptors in anti-chromatin B cell regulation. Int Immunol 2007, 19:465-475.
27. Clatworthy M.R., Espeli M., Torpey N., Smith K.G. The generation and maintenance of serum alloantibody. Curr Opin Immunol 2010, 22:669-681.
28. Lund F.E., Randall T.D. Effector and regulatory B cells: modulators of CD4(+) T cell immunity. Nat Rev Immunol 2010, 10:236-247.
29. Noorchashm H., Reed A.J., Rostami S.Y., Mozaffari R., Zekavat G., Koeberlein B., et al. B cell-mediated antigen presentation is required for the pathogenesis of acute cardiac allograft rejection. J Immunol 2006, 177:7715-7722.
30. Ng Y.L.Q., Marlowe A., Hoffman R., Chalasani G. Antigen presentation by B cells promotes heart allograft rejection and development of alloreactive memory T cells. Am J Transplant 2008, 8(S2):269.
31. Ng Y.H., Oberbarnscheidt M.H., Chandramoorthy H.C., Hoffman R., Chalasani G B cells help alloreactive T cells differentiate into memory T cells. Am J Transplant 2010, 10(9):1970-1980.
32. Shlomchik M.J. Sites and stages of autoreactive B cell activation and regulation. Immunity 2008, 28:18-28.
33. Parsons R.F., Vivek K., Rostami S.Y., Zekavat G., Ziaie S.M., Luo Y., et al. Acquisition of humoral transplantation tolerance upon de novo emergence of B lymphocytes. J Immunol 2010, 186:614-620.
34. Li Y., Ma L., Shen J., Chong A.S. Peripheral deletion of mature alloreactive B cells induced by costimulation blockade. Proc Natl Acad Sci USA 2007, 104:12093-12098.
35. Fan X., Ang A., Pollock-Barziv S.M., Dipchand A.I., Ruiz P., Wilson G., et al. Donor-specific B-cell tolerance after ABO-incompatible infant heart transplantation. Nat Med 2004, 10:1227-1233.
36. Urschel S., Campbell P.M., Meyer S.R., Larsen I.M., Nuebel J., Birnbaum J., et al. Absence of donor-specific anti-HLA antibodies after ABO-incompatible heart transplantation in infancy: altered immunity or age?. Am J Transplant 2009, 10:149-156.
37. Parsons R.F., Vivek K., Redfield R.R., Migone T.S., Cancro M.P., Naji A., et al. B-cell tolerance in transplantation: is repertoire remodeling the answer?. Expert Rev Clin Immunol 2009, 5:703.
38. Bloom D., Chang Z., Pauly K., Kwun J., Fechner J., Hayes C., et al. BAFF is increased in renal transplant patients following treatment with alemtuzumab. Am J Transplant 2009, 9:1835-1845.
39. Miller J.P., Stadanlick J.E., Cancro M.P. Space, selection, and surveillance: setting boundaries with BLyS. J Immunol 2006, 176:6405-6410.
40. Zekavat G., Rostami S.Y., Badkerhanian A., Parsons R.F., Koeberlein B., Yu M., et al. In vivo BLyS/BAFF neutralization ameliorates islet-directed autoimmunity in nonobese diabetic mice. J Immunol 2008, 181:8133-8144.
41. Diwan T.S., Raghavaiah S., Burns J.M., Kremers W.K., Gloor J.M., Stegall M.D. The impact of proteasome inhibition on alloantibody-producing plasma cells in vivo. Transplantation 2011, 91:536-541.
42. Newell K.A., Asare A., Kirk A.D., Gisler T.D., Bourcier K., Suthanthiran M., et al. Identification of a B cell signature associated with renal transplant tolerance in humans. J Clin Invest 2010, 120:1836-1847.
43. Reichardt P., Dornbach B., Rong S., Beissert S., Gueler F., Loser K., et al. cells generate regulatory T cells in the presence of a mature immunologic synapse. Blood 2007, 110:1519-1529.
44. Fuchs E.J., Matzinger P. B cells turn off virgin but not memory T cells. Science 1992, 258:1156-1159.
45. Parker D.C., Greiner D.L., Phillips N.E., Appel M.C., Steele A.W., Durie F.H., et al. Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand. Proc Natl Acad Sci USA 1995, 92:9560-9564.
46. Kopchaliiska D., Zachary A.A., Montgomery R.A., Leffell M.S. Reconstitution of peripheral allospecific CD19+ B-cell subsets after B-lymphocyte depletion therapy in renal transplant patients. Transplantation 2009, 87:1394-1401.
47. Liu C., Noorchashm H., Sutter J.A., Naji M., Prak E.L., Boyer J., et al. B lymphocyte-directed immunotherapy promotes long-term islet allograft survival in nonhuman primates. Nat Med 2007, 13:1295-1298.
48. Parsons R.F., Vivek K., Redfield R.R., Migone T.S., Cancro M.P., Naji A. Noorchashm H: B-lymphocyte homeostasis and BLyS-directed immunotherapy in transplantation. Transplant Rev (Orlando) 2010, 24:207-221.
49. Fillatreau S., Sweenie C.H., McGeachy M.J., Gray D., Anderton S.M. B cells regulate autoimmunity by provision of IL-10. Nat Immunol 2002, 3:944-950.
50. Mauri C., Gray D., Mushtaq N., Londei M. Prevention of arthritis by interleukin 10-producing B cells. J Exp Med 2003, 197:489-501.
51. Mizoguchi A., Mizoguchi E., Takedatsu H., Blumberg R.S., Bhan A.K. Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity 2002, 16:219-230.
52. Lenert P., Brummel R., Field E.H., Ashman R.F. TLR-9 activation of marginal zone B cells in lupus mice regulates immunity through increased IL-10 production. J Clin Immunol 2005, 25:29-40.
53. Blair P.A., Norena L.Y., Flores-Borja F., Rawlings D.J., Isenberg D.A., Ehrenstein M.R., et al. CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients. Immunity 2010, 32:129-140.
54. Carter N.A., Vasconcellos R., Rosser E.C., Tulone C., Munoz-Suano A., Kamanaka M., et al. Mice lacking endogenous IL-10-producing regulatory B cells develop exacerbated disease and present with an increased frequency of Th1/Th17 but a decrease in regulatory T cells. J Immunol 2011, 186:5569-5579.